Continuous Development of GLP-1 Agonists Drives Dominance in the Diabetes Drug Market
August 11, 2023 07:58 ET
|
Research and Markets
Dublin, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The "Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Insulin Drugs Global Market Research Report 2023
March 27, 2023 10:18 ET
|
Research and Markets
Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Insulin Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global insulin drugs market will grow from...
The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
October 12, 2022 07:33 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Global Diabetes Drug Market Research Report 2022: Size, Forecasts, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis 2021-2027
May 04, 2022 04:23 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
November 26, 2021 07:53 ET
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
United States $46 Billion Biosimilar Insulin Market Opportunity & Clinical Trials Forecasts to 2026
August 27, 2021 06:13 ET
|
Research and Markets
Dublin, Aug. 27, 2021 (GLOBE NEWSWIRE) -- The "US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The US...
Global Antidiabetic Drug Markets Report 2021: A-Glucosidase Inhibitors, Biguanides, DPP-IV Inhibitors, Meglitinides, Sulfonylureas, Thiazolidinediones - Forecast to 2026
August 25, 2021 09:23 ET
|
Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of Covid-19 with...
United States Diabetes Drug Market Report 2021-2026: Dosage, Formulation, Patent, Pricing Insight by Drug Class
February 24, 2021 08:08 ET
|
Research and Markets
Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026" report has been added to ResearchAndMarkets.com's offering. As per the "US...
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Outlook 2025: Investments & Collaborations by Leading Market Players
September 15, 2020 05:28 ET
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025" report has been added to ResearchAndMarkets.com's offering. ...